Shen S - Search Results

Year	Number of Results
1944	4
1946	1
1947	2
1948	2
1949	1
1950	3
1951	1
1952	3
1953	2
1954	2
1955	1
1956	1
1957	2
1958	2
1959	7
1960	1
1961	1
1962	2
1963	1
1964	3
1965	5
1966	1
1967	1
1969	1
1970	1
1971	1
1972	1
1973	3
1974	1
1975	4
1976	6
1977	4
1978	5
1979	5
1980	8
1981	10
1982	7
1983	9
1984	12
1985	13
1986	19
1987	16
1988	10
1989	29
1990	11
1991	14
1992	17
1993	34
1994	53
1995	26
1996	35
1997	30
1998	47
1999	51
2000	44
2001	58
2002	69
2003	81
2004	98
2005	150
2006	134
2007	150
2008	162
2009	189
2010	217
2011	191
2012	240
2013	336
2014	354
2015	417
2016	392
2017	431
2018	481
2019	583
2020	706
2021	792
2022	890
2023	882
2024	414

1

Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment.

Ma C, Yang C, Peng A, Sun T, Ji X, Mi J, Wei L, Shen S, Feng Q. Ma C, et al. Among authors: shen s. Mol Cancer. 2023 Oct 13;22(1):170. doi: 10.1186/s12943-023-01876-x. Mol Cancer. 2023. PMID: 37833788 Free PMC article.

2

The tRNA-GCN2-FBXO22-axis-mediated mTOR ubiquitination senses amino acid insufficiency.

Ge MK, Zhang C, Zhang N, He P, Cai HY, Li S, Wu S, Chu XL, Zhang YX, Ma HM, Xia L, Yang S, Yu JX, Yao SY, Zhou XL, Su B, Chen GQ, Shen SM. Ge MK, et al. Among authors: shen sm. Cell Metab. 2023 Dec 5;35(12):2216-2230.e8. doi: 10.1016/j.cmet.2023.10.016. Epub 2023 Nov 17. Cell Metab. 2023. PMID: 37979583

3

Klebsiella pneumoniae carbapenemase variants: the new threat to global public health.

Ding L, Shen S, Chen J, Tian Z, Shi Q, Han R, Guo Y, Hu F. Ding L, et al. Among authors: shen s. Clin Microbiol Rev. 2023 Dec 20;36(4):e0000823. doi: 10.1128/cmr.00008-23. Epub 2023 Nov 8. Clin Microbiol Rev. 2023. PMID: 37937997 Free PMC article. Review.

4

Drug-tolerant persister cells in cancer: the cutting edges and future directions.

Pu Y, Li L, Peng H, Liu L, Heymann D, Robert C, Vallette F, Shen S. Pu Y, et al. Among authors: shen s. Nat Rev Clin Oncol. 2023 Nov;20(11):799-813. doi: 10.1038/s41571-023-00815-5. Epub 2023 Sep 25. Nat Rev Clin Oncol. 2023. PMID: 37749382 Review.

5

Osteocyte-derived sclerostin impairs cognitive function during ageing and Alzheimer's disease progression.

Shi T, Shen S, Shi Y, Wang Q, Zhang G, Lin J, Chen J, Bai F, Zhang L, Wang Y, Gong W, Shao X, Chen G, Yan W, Chen X, Ma Y, Zheng L, Qin J, Lu K, Liu N, Xu Y, Shi YS, Jiang Q, Guo B. Shi T, et al. Among authors: shen s. Nat Metab. 2024 Mar;6(3):531-549. doi: 10.1038/s42255-024-00989-x. Epub 2024 Feb 26. Nat Metab. 2024. PMID: 38409606

6

Deep whole-genome analysis of 494 hepatocellular carcinomas.

Chen L, Zhang C, Xue R, Liu M, Bai J, Bao J, Wang Y, Jiang N, Li Z, Wang W, Wang R, Zheng B, Yang A, Hu J, Liu K, Shen S, Zhang Y, Bai M, Wang Y, Zhu Y, Yang S, Gao Q, Gu J, Gao D, Wang XW, Nakagawa H, Zhang N, Wu L, Rozen SG, Bai F, Wang H. Chen L, et al. Among authors: shen s. Nature. 2024 Mar;627(8004):586-593. doi: 10.1038/s41586-024-07054-3. Epub 2024 Feb 14. Nature. 2024. PMID: 38355797

7

One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.

Li N, Tan F, Chen W, Dai M, Wang F, Shen S, Tang W, Li J, Yu Y, Cao W, Xu Y, Qin C, Zhao L, Zhu M, Guo L, Wu Z, Yang Z, Zheng Y, Chen H, Liu Y, Wei D, Dong D, Cao J, Zhang S, Yan S, Wang N, Du L, Shen H, Wu N, He J; National Lung Cancer Screening programme group. Li N, et al. Among authors: shen s. Lancet Respir Med. 2022 Apr;10(4):378-391. doi: 10.1016/S2213-2600(21)00560-9. Epub 2022 Mar 8. Lancet Respir Med. 2022. PMID: 35276087

8

Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8⁺ T-cell exhaustion.

Gu X, Wei H, Suo C, Shen S, Zhu C, Chen L, Yan K, Li Z, Bian Z, Zhang P, Yuan M, Yu Y, Du J, Zhang H, Sun L, Gao P. Gu X, et al. Among authors: shen s. Nat Commun. 2023 Dec 9;14(1):8154. doi: 10.1038/s41467-023-43988-4. Nat Commun. 2023. PMID: 38071226 Free PMC article.

9

Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application.

Ren X, Huang M, Weng W, Xie Y, Wu Y, Zhu S, Zhang Y, Li D, Lai J, Shen S, Lin J, Kuang M, Li X, Yu J, Xu L. Ren X, et al. Among authors: shen s. Cell Rep Med. 2023 Nov 21;4(11):101277. doi: 10.1016/j.xcrm.2023.101277. Epub 2023 Nov 8. Cell Rep Med. 2023. PMID: 37944531 Free PMC article.

10

Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.

Zhang L, Zhang Y, Shen S, Wang X, Dong L, Li Q, Ren W, Li Y, Bai J, Gong Q, Kuang H, Qi L, Lu Q, Cheng W, Liu Y, Yan S, Wu D, Fang H, Hou F, Wang Y, Yang Z, Lian X, Du J, Sun N, Ji L, Li G; China Diabetes Prevention Program Study Group. Zhang L, et al. Among authors: shen s. Lancet Diabetes Endocrinol. 2023 Aug;11(8):567-577. doi: 10.1016/S2213-8587(23)00132-8. Epub 2023 Jul 3. Lancet Diabetes Endocrinol. 2023. PMID: 37414069 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8,117 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8,117 results

Results by year